Literature DB >> 1154462

Regional cerebral blood flow estimated by 133-xenon inhalation.

W D Obrist, H K Thompson, H S Wang, W E Wilkinson.   

Abstract

A method is described for estimating the clearance rate and fractional blood flow of the fast (gray matter) compartment of the brain from the first ten minutes of 122 XE clearance curves, following a one-minute inhalation. Computer-simulated data were used to test the adequacy of the two-compartmental model employed, and to evaluate the stability of the parameters in the presence of random noise. A comparison was made between this approach and the previously reported three-compartmental analysis. Regional cerbral blood flow data were obtained on 48 young control subjects and 20 elderly demented patients. Hemispheral, regional, and test-retest variations were determined, as well as differences between the groups.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1154462     DOI: 10.1161/01.str.6.3.245

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  93 in total

1.  Physiologic changes in regional cerebral blood flow defined by xenon-enhanced CT scanning.

Authors:  B P Drayer; S K Wolfson; M Boehnke; M Dujovny; A E Rosenbaum; E E Cook
Journal:  Neuroradiology       Date:  1978       Impact factor: 2.804

2.  Long-term effects of boxing and judo-choking techniques on brain function.

Authors:  G Rodriguez; P Vitali; F Nobili
Journal:  Ital J Neurol Sci       Date:  1998-12

3.  Grading and outcome prediction of cases of aneurysmal subarachnoid haemorrhage by bedside xenon cerebral blood flowmetry.

Authors:  M M Kotb; L Symon; J Compton; J Rosenstein; A Jabre
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

4.  Adenosine receptor-dependent signaling is not obligatory for normobaric and hypobaric hypoxia-induced cerebral vasodilation in humans.

Authors:  Ryan L Hoiland; Anthony R Bain; Michael M Tymko; Mathew G Rieger; Connor A Howe; Christopher K Willie; Alex B Hansen; Daniela Flück; Kevin W Wildfong; Mike Stembridge; Prajan Subedi; James Anholm; Philip N Ainslie
Journal:  J Appl Physiol (1985)       Date:  2017-01-12

5.  Redistribution of blood flow in the cerebral cortex of normal subjects during head-up postural change.

Authors:  S Warkentin; U Passant; L Minthon; S Karlson; L Edvinsson; R Fäldt; L Gustafson; J Risberg
Journal:  Clin Auton Res       Date:  1992-04       Impact factor: 4.435

6.  Semiquantifying regional cerebral blood flow by 123I-amphetamine (IMP) SPECT in cerebrovascular disorders: correlations with CBF indices by 133Xe inhalation method.

Authors:  Y Tsuda; A Hartmann; H J Biersack; E Valerius; K Broich; K Reichmann
Journal:  Eur J Nucl Med       Date:  1988

7.  The effects of bromvincamine and vincamine on regional cerebral blood flow and mental functions in patients with multi-infarct dementia.

Authors:  S Hagstadius; L Gustafson; J Risberg
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Hyperemia following aneurysmal subarachnoid hemorrhage: incidence, diagnosis, clinical features, and outcome.

Authors:  Ralf Dirk Rothoerl; Chris Woertgen; Alexander Brawanski
Journal:  Intensive Care Med       Date:  2004-04-09       Impact factor: 17.440

Review 9.  Multimodal brain monitoring in fulminant hepatic failure.

Authors:  Fernando Mendes Paschoal; Ricardo Carvalho Nogueira; Karla De Almeida Lins Ronconi; Marcelo de Lima Oliveira; Manoel Jacobsen Teixeira; Edson Bor-Seng-Shu
Journal:  World J Hepatol       Date:  2016-08-08

10.  Noninvasive measurement of cerebral blood flow and blood oxygenation using near-infrared and diffuse correlation spectroscopies in critically brain-injured adults.

Authors:  Meeri N Kim; Turgut Durduran; Suzanne Frangos; Brian L Edlow; Erin M Buckley; Heather E Moss; Chao Zhou; Guoqiang Yu; Regine Choe; Eileen Maloney-Wilensky; Ronald L Wolf; M Sean Grady; Joel H Greenberg; Joshua M Levine; Arjun G Yodh; John A Detre; W Andrew Kofke
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.